Cargando…
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis
BACKGROUND: Post-acute coronavirus 2019 (COVID-19) syndrome is now recognized as a complex systemic disease that is associated with substantial morbidity. OBJECTIVES: To estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods. DA...
Autores principales: | Alkodaymi, Mohamad Salim, Omrani, Osama Ali, Fawzy, Nader A., Shaar, Bader Abou, Almamlouk, Raghed, Riaz, Muhammad, Obeidat, Mustafa, Obeidat, Yasin, Gerberi, Dana, Taha, Rand M., Kashour, Zakaria, Kashour, Tarek, Berbari, Elie F., Alkattan, Khaled, Tleyjeh, Imad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812092/ https://www.ncbi.nlm.nih.gov/pubmed/35124265 http://dx.doi.org/10.1016/j.cmi.2022.01.014 |
Ejemplares similares
-
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Kashour, Zakariya, et al.
Publicado: (2021) -
A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on WHO International Clinical Trials Platform
por: Fawzy, Nader A., et al.
Publicado: (2023) -
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis
por: Yetmar, Zachary A, et al.
Publicado: (2021) -
It is time to drop hydroxychloroquine from our COVID-19 armamentarium
por: Kashour, Tarek, et al.
Publicado: (2020) -
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City
por: Tleyjeh, Imad M., et al.
Publicado: (2021)